Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

Nitroglycerin for treatment of retained placenta: a randomized, placebo-controlled, multicentre double blind trial in the UK

Denison FC. et al, (2019), PLoS Medicine

Correction: Delivering genomic medicine in the UK National Health Service: a systematic review and narrative synthesis.

Pearce C. et al, (2019), Genet Med, 21

CLINICIAN-RESEARCHERS AND CUSTODIANS OF SCARCE RESOURCES: A QUALITATIVE STUDY OF HEALTH PROFESSIONALS’ VIEWS ON BARRIERS TO TEENAGERS AND YOUNG ADULTS’ INVOLVEMENT IN CANCER TRIALS

Hart RI. et al, (2019), Trials

Does the type of disease matter when receiving secondary findings? A qualitative vignette study on Finnish adults' views

Vornanen M. et al, (2019), EUROPEAN JOURNAL OF HUMAN GENETICS, 27, 716 - 716

Mainstreaming BRCA1 and BRCA2 testing: an interview study of healthcare professionals' views

Wright S. et al, (2019), EUROPEAN JOURNAL OF HUMAN GENETICS, 27, 664 - 665

Moving into the mainstream: Treatment focussed genetic testing a screening tool or diagnostic resource?

Hallowell N. et al, (2019), EUROPEAN JOURNAL OF HUMAN GENETICS, 27, 704 - 704

Lay Perspectives on Receiving Different Types of Genomic Secondary Findings: a Qualitative Vignette Study.

Vornanen M. et al, (2019), J Genet Couns, 28, 343 - 354

Negotiating jurisdictional boundaries in response to new genetic possibilities in breast cancer care: The creation of an ‘oncogenetic taskscape’

Wright S. et al, (2019), Social Science & Medicine

Moving into the mainstream: healthcare professionals' views of implementing treatment focussed genetic testing in breast cancer care.

Hallowell N. et al, (2019), Fam Cancer

Enabling Global Clinical Collaborations on Identifiable Patient Data: The Minerva Initiative.

Nellåker C. et al, (2019), Front Genet, 10

How should decision aids be used during counseling to help patients who are "genetically at risk"?

Evans N. et al, (2019), AMA Journal of Ethics, 21, 865 - 872

'I would like to discuss it further with an expert': a focus group study of Finnish adults' perspectives on genetic incidental findings

Vornanen M. et al, (2018), EUROPEAN JOURNAL OF HUMAN GENETICS, 26, 816 - 816

Lay Perspectives on Receiving Different Types of Genomic Secondary Findings: a Qualitative Vignette Study.

Vornanen M. et al, (2018), J Genet Couns

High-risk women's risk perception after receiving personalized polygenic breast cancer risk information.

Forrest LE. et al, (2018), J Community Genet

"I would like to discuss it further with an expert": a focus group study of Finnish adults' perspectives on genetic secondary findings.

Vornanen M. et al, (2018), J Community Genet, 9, 305 - 314

Big data phenotyping in rare diseases: some ethical issues.

Hallowell N. et al, (2018), Genet Med

Making Sense of SNPs: Women's Understanding and Experiences of Receiving a Personalized Profile of Their Breast Cancer Risks.

Young M-A. et al, (2018), J Genet Couns, 27, 702 - 708

Research or clinical care: what's the difference?

Hallowell N., (2018), J Med Ethics, 44, 359 - 360

Patients' Views of Treatment-Focused Genetic Testing (TFGT): Some Lessons for the Mainstreaming of BRCA1 and BRCA2 Testing.

Wright S. et al, (2018), J Genet Couns

Better governance, better access: practising responsible data sharing in the METADAC governance infrastructure.

Murtagh MJ. et al, (2018), Hum Genomics, 12

Load More

1
2
3
4
5
6
7

Include forthcoming?